To capture the successes and challenges that arise with a national introduction of the HPV vaccine in low-and lower-middle income countries and to gain a better understanding of program transition to national scale-up, program preparation and communication, program delivery and financial implications for long-term sustainability.

To conduct targeted assessments involving vaccine research and surveillance. The current studies range from a meningitis carriage study in Burkina Faso to measure the impact of the MenA vaccine, to rotavirus surveillance in Mozambique to look at vaccine effectiveness.

To provide evidence about the public health impact and benefits on child health after the introduction of rotavirus vaccine into the Pakistan National Immunization Program system.

To strengthen vaccine-preventable disease surveillance platforms to maximize their capacity to measure burden of disease and to monitor the impact of vaccines. Activities include improving immunization data quality; evaluating impact and implementation of vaccines (including oral cholera, rubella, and HPV); improving the quality and planning of measles and rubella campaigns; and strengthening surveillance for vaccine preventable diseases (meningitis, diphtheria and pertussis, intussusception).

To honor CDC's 50th anniversary and the 25th anniversary of the first combination vaccine for measles, mumps and rubella, this award funds an annual lecture at CDC's National Immunization Conference by an individual whose work or leadership has made significant contributions to the elimination of measles, mumps, or rubella or individuals who have contributed to the elimination of any pediatric disease and immunization overall.

To generate data on the effectiveness and impact of rotavirus vaccination in early introducing regions of India and help establish a platform for assessment of safety with respect to intussusception.